U.S. Capital Markets Stock News

BWX Technologies has delivered a very strong run over the last five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks currently point to the stock trading at a premium to those fundamentals. BWX Technologies has returned 215.2% over five years, which sets a high bar for any further upside to be supported by fundamentals. The company’s valuation can be supported by expectations for continued cash flow generation from its core defense and...

United Therapeutics (UTHR) stock is in focus after the company reported statistically significant phase 3 ADVANCE OUTCOMES results for its investigational PAH therapy ralinepag, with full data recently published in The Lancet. See our latest analysis for United Therapeutics. The latest ralinepag data and board appointment of Dr. Victor Dzau come as United Therapeutics trades at US$524.70, with the share price return up 5.63% year to date but the 90-day share price return down 8.16%. Over a...

Chubb stock has delivered a strong 126.4% total return over the past 5 years, yet the current checks send a mixed message, with the Excess Returns intrinsic value estimate suggesting the shares trade at a sizeable discount while the broader valuation framework does not flag the stock as an obvious bargain. Over 5 years, Chubb has returned 126.4%, which puts recent share price strength at the center of any valuation discussion. Future expectations for underwriting quality and capital...

In July 2026, Harley-Davidson, Inc. reported that second-quarter net income fell to US$79.81 million from US$107.57 million a year earlier, with first-half net income dropping to US$104.58 million from US$240.67 million, while continuing to execute its share repurchase program. Despite the weaker earnings, Harley-Davidson has completed repurchases totaling 24,470,194 shares for about US$1.33 billion since July 2024, signaling ongoing capital returns even as profitability softens. Next, we’ll...

FMC earnings jolt investor focus FMC (FMC) is in the spotlight after reporting second quarter 2026 results that showed lower sales and a move from profit to loss, alongside updated revenue guidance pointing to a full year decline. See our latest analysis for FMC. The earnings miss and lower full year revenue guidance have come alongside heavy selling in FMC, with the share price down 8.5% on the day of the report and the 1 year total shareholder return falling 74.9%. This hints at fading...

Omnicom Group walked into this earnings print with the stock quietly grinding higher in recent weeks. Today that calm broke. Shares were down about 4% intraday after the release, even as the core advertising and marketing engine delivered a sharp earnings punch. The headline this quarter is profit power, not top line drama. Non GAAP adjusted earnings per share landed at US$2.65, and core adjusted EBITA margin sat near 17.8%. That is the story the market is wrestling with: a lower share price...

Old National Bancorp recently reported second-quarter 2026 results, with net interest income of US$578.99 million, net income of US$253.41 million, diluted EPS of US$0.65, net charge-offs of US$32.2 million, and completion of a buyback totaling 5,148,549 shares for US$123.5 million. This combination of higher earnings, stable credit costs, and active capital return gives investors fresh information on the bank’s current profitability and balance sheet management. We’ll now assess how this...

Madrigal Pharmaceuticals, Inc. has reported past second-quarter 2026 results showing a net loss of US$57.94 million and basic and diluted loss per share of US$1.99, widening from US$42.28 million and US$1.50 per share a year earlier, despite beating analyst expectations on earnings and revenue. Alongside this, the company highlighted growing Rezdiffra sales in MASH, new patents extending protection for resmetirom, and the start of Phase 1 testing for its oral GLP-1 candidate MGL-2086 aimed...

In recent weeks, Bitmine Immersion Technologies accelerated its Ethereum accumulation to nearly 5% of circulating supply and stepped up a US$4.00 billion share repurchase program, while its chairman publicly emphasized Ethereum’s growing role in digital asset infrastructure and policy debates. This combination of aggressive treasury activity and vocal advocacy has positioned Bitmine as a high-profile proxy for institutional interest in Ethereum’s broader ecosystem. We’ll now examine how...

Why the upcoming Q2 2026 earnings date matters for Hub Group Hub Group (HUBG) is set to report estimated Q2 2026 results on July 30, an event that puts fresh attention on the stock after a period of mixed operating signals. With revenue and net income figures already available for the most recent full year, and a recent share price of US$47.69, the upcoming update provides a new checkpoint on how the business is tracking. See our latest analysis for Hub Group. The upcoming Q2 update lands as...

Columbia Banking System (COLB) drew fresh attention on July 23, 2026, after reporting second quarter earnings, updated net charge-offs of $30 million, and progress on a multi-hundred-million-dollar share repurchase. See our latest analysis for Columbia Banking System. At a share price of $30.78, Columbia Banking System has seen short term share price pressure, with a 7 day share price return down 5.67%, while the year to date share price return of 9.19% and 1 year total shareholder return of...

Patrick Industries, Inc. has reported past second-quarter 2026 results showing sales of US$1,041.7 million, with net income rising to US$43.42 million and diluted earnings per share from continuing operations increasing to US$1.28 compared with the prior year. Despite slightly lower year-to-date sales versus the same period last year, Patrick Industries delivered higher profitability and earnings per share, underscoring the impact of margin improvement and cost discipline on its overall...

After a near doubling in the last year, Veeco Instruments now sits in a zone where recent gains and the latest valuation checks are no longer pointing to an obvious bargain, even though the share price has pulled back sharply in the past month. Veeco Instruments has returned 97.7% over the past year, which puts the recent selloff into context and raises the question of how much of the good news may already be reflected in the price. Future expectations for revenue growth and cash generation...

In the second quarter of 2026, QuantumScape Corporation reported a net loss of US$98.24 million and basic loss per share of US$0.16, both lower than the same period in 2025. Over the first half of 2026, QuantumScape cut its cumulative net loss to US$199.04 million and loss per share to US$0.32, highlighting a slower cash burn as it continues to fund solid-state battery development. Next, we will assess how this narrower quarterly net loss shapes QuantumScape’s investment narrative built...

Navios Maritime Partners has delivered very strong long term returns over the past five years, yet the current valuation checks still suggest the stock leans cheap rather than stretched. The stock has returned about 262.5% over 5 years. This puts a lot of focus on whether today’s price still offers a margin of safety. For a shipping partnership like Navios Maritime Partners, investor expectations around shipping rates and fleet utilisation can support the current valuation. At the same time,...

Talos Energy (TALO) is drawing attention ahead of its upcoming June 2026 quarter earnings report, with expectations for significant earnings growth and a positive Earnings ESP refocusing investor interest on the stock. See our latest analysis for Talos Energy. Talos Energy's share price has moved to $14.25 after a 1-day share price return of 4.24%, with the year to date share price return of 26.67% and 1-year total shareholder return of 61.20% pointing to building momentum despite some recent...

Renasant stock barely flinched after earnings, easing about 1% in Thursday trading, yet the results were anything but sleepy. The real story sits in profitability. Adjusted earnings per share for the quarter came in just under US$1, and net income held close to US$90 million, supported by a solid net interest margin and a tighter cost to income ratio than a year ago. Investors saw a quiet price move into these numbers and a much louder message in the income statement. The rest of the release...

Harrow recently presented three studies at the ASRS 2026 Annual Meeting highlighting interim clinical and real-world data for IHEEZO and BYOOVIZ in retinal care. The early IHEEZO data suggesting improved post-injection comfort without added antisepsis risk could meaningfully influence how ophthalmologists think about intravitreal procedures. We’ll now explore how encouraging interim IHEEZO pain and safety findings may influence Harrow’s investment narrative built around retina...

Four Corners Property Trust (FCPT) has combined an upsized credit facility with its largest acquisition to date, the Mission Pet Health portfolio, giving investors fresh information on both balance sheet structure and portfolio mix. See our latest analysis for Four Corners Property Trust. At a share price of $26.33, Four Corners Property Trust has recorded a 13.30% year to date share price return. The 1 year total shareholder return of 8.91% sits alongside multi year total shareholder returns...

Global markets are wrestling with mixed inflation signals, shifting rate expectations and higher energy costs. That backdrop keeps investors focused on assets that can potentially benefit as digital infrastructure and new transaction systems evolve. The Top Cryptocurrency and Blockchain Stocks screener filters this wide universe into a more manageable starting list based on clear, transparent criteria. That helps you focus on businesses linked to crypto and blockchain themes without having to...

Murphy Oil previously announced it was expected to report higher year-over-year earnings and revenues for the June 2026 quarter, with the earnings release scheduled for August 5 and analyst models indicating a likely earnings beat based on an Earnings ESP of 0.25% and a Zacks Rank of 3. An interesting angle for investors is Murphy Oil’s consistent record of surpassing consensus EPS estimates in each of the last four quarters, which has fueled confidence in the company’s upcoming results...

In recent weeks, Buckley Capital Advisors highlighted Liquidia Corporation in its Q2 2026 investor letter, crediting the company as a major contributor to portfolio gains and expressing confidence in a favorable judicial ruling on Liquidia’s ability to sell Yutrepia for PH-ILD. This external investor commentary has sharpened attention on Liquidia’s legal outcomes and potential buyout interest, adding an additional layer of focus to the company’s existing product, earnings and pipeline...

Bicara Therapeutics recently appointed Jeremy Bender, Ph.D., MBA, former CEO of Day One Biopharmaceuticals, and ex-Genentech oncology leader Christy Oliger to its Board of Directors, while Kiran Mazumdar-Shaw retired from the board. The additions bring deep experience in oncology drug launches, large-scale portfolio management and major biotech M&A, potentially influencing how Bicara approaches late-stage development and commercialization decisions. Next, we’ll examine how adding experienced...

Globus Medical (GMED) stock drew renewed attention after its recent trading move, with the price closing at $81.42. Investors are now reassessing how its business profile and valuation stack up. See our latest analysis for Globus Medical. That latest move sits within a mixed picture. The 7 day share price return of 7.84% contrasts with a 30 day share price decline of 3% and a 90 day share price decline of 9.71%, while the 1 year total shareholder return of 52.33% points to stronger long run...